ARCHIVES

DCT Board Approves New RFA For Aids Clinical Trials Groups

This article is from The Cancer Letter archive.

Vol. 20 No. 43 | November 11, 1994

Download PDF Visit The Full Archive

Related Articles

Kadcyla Extends Median PFS In Open-Label Phase III Trial

October 25, 2013

DePinho’s Handling Of MD Anderson Tenure Dispute Triggers Formal Investigation by AAUP

July 18, 2014

NCAB To Study Recommendations On Cooperative Groups, Coordination Of NCI Treatment Programs

June 20, 1975

Drug Approvals; Zykadia Granted Accelerated Approval For ALK+ NSCLC; ADXS-HPV Grated Orphan Drug Designation

May 9, 2014

Appreciation: Quack-Buster Saul Green Used Science to Debunk Alternative Medicine Claims.

July 13, 2007

Ellence Has Lower Risk Of Heart Damage, Study Finds

August 27, 2004